Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

217 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Factors contributing to the rise of buprenorphine misuse: 2008-2013.
Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. Cicero TJ, et al. Drug Alcohol Depend. 2014 Sep 1;142:98-104. doi: 10.1016/j.drugalcdep.2014.06.005. Epub 2014 Jun 18. Drug Alcohol Depend. 2014. PMID: 24984689
Understanding the use of diverted buprenorphine.
Cicero TJ, Ellis MS, Chilcoat HD. Cicero TJ, et al. Drug Alcohol Depend. 2018 Dec 1;193:117-123. doi: 10.1016/j.drugalcdep.2018.09.007. Epub 2018 Oct 12. Drug Alcohol Depend. 2018. PMID: 30359928 Free article.
Increases in self-reported fentanyl use among a population entering drug treatment: The need for systematic surveillance of illicitly manufactured opioids.
Cicero TJ, Ellis MS, Kasper ZA. Cicero TJ, et al. Drug Alcohol Depend. 2017 Aug 1;177:101-103. doi: 10.1016/j.drugalcdep.2017.04.004. Epub 2017 May 30. Drug Alcohol Depend. 2017. PMID: 28582697
Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004.
Cicero TJ, Inciardi JA, Adams EH, Geller A, Senay EC, Woody GE, Muñoz A. Cicero TJ, et al. Pharmacoepidemiol Drug Saf. 2005 Dec;14(12):851-9. doi: 10.1002/pds.1113. Pharmacoepidemiol Drug Saf. 2005. PMID: 15892169
Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur.
Senay EC, Adams EH, Geller A, Inciardi JA, Muñoz A, Schnoll SH, Woody GE, Cicero TJ. Senay EC, et al. Drug Alcohol Depend. 2003 Apr 1;69(3):233-41. doi: 10.1016/s0376-8716(02)00321-6. Drug Alcohol Depend. 2003. PMID: 12633909
Trends in opioid analgesic abuse and mortality in the United States.
Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, Green JL. Dart RC, et al. N Engl J Med. 2015 Jan 15;372(3):241-8. doi: 10.1056/NEJMsa1406143. N Engl J Med. 2015. PMID: 25587948
Abuse Deterrent Formulations of Prescription Opioids--Reply.
Cicero TJ, Ellis MS. Cicero TJ, et al. JAMA Psychiatry. 2015 Aug;72(8):850-1. doi: 10.1001/jamapsychiatry.2015.0674. JAMA Psychiatry. 2015. PMID: 26153921 No abstract available.
217 results
Jump to page
Feedback